SCHEMBL1633103

SCHEMBL1633103

O=S(=O)(c1cccc(Nc2ncc3c(Br)ccc(OC4CCNCC4)c3n2)c1)N1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.44
JAK1 P23458 1/20 0.44
TYK2 P29597 1/20 0.44
JAK3 P52333 1/20 0.44
IGF1R P08069 1/20 0.44
CCNT1 O60563 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
CDK7 P50613 1/20 0.43
CDK9 P50750 1/20 0.43
CCNH P51946 1/20 0.43
BMPR2 Q13873 1/20 0.43
ERBB2 P04626 4/20 0.41
PTK6 Q13882 3/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
BRD4 O60885 2/20 0.41
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632510 0.91 IGF1R (0.51) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1633493 0.88 JAK2 (0.58) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1633571 0.86 TBK1 (0.54) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1633304 0.83 CCNT1 (0.45) CCNT1CDK1CCNB1CCNA2CDK2
SCHEMBL1633537 0.82 SYK (0.50) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1632734 0.82 IGF1R (0.46) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1633643 0.81 CDK4 (0.51) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1632132 0.81 IGF1R (0.46) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1633919 0.80 JAK2 (0.50) JAK2JAK1TYK2JAK3TBK1
SCHEMBL1633848 0.80 JAK2 (0.60) JAK2JAK1TYK2JAK3IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed